Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Plus Therapeutics Inc PSTV

Healthcare Biotechnology
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The Company combines image-guided local beta radiation and targeted drug delivery approaches. The Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma... see more

Recent & Breaking News (NDAQ:PSTV)

25 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  February 15, 2017

Cytori Completes Acquisition of Azaya Therapeutics Assets, Initiates Nanomedicine Program

GlobeNewswire February 15, 2017

Cytori Provides Latest Corporate Update at the 2nd Annual Disruptive Growth & Healthcare Conference

GlobeNewswire February 14, 2017

Cytori Receives U.S. Small Business Designation - Substantially Reduces 2017 FDA Filing Fees

GlobeNewswire February 6, 2017

Cytori to Acquire Proprietary Nanoparticle Development Platform to Enhance Regenerative Medicine Leadership Position

GlobeNewswire January 19, 2017

Cytori to Expand Scleroderma Focus to Broader Hand Therapy Franchise Under the Habeo™ Cell Therapy Brand

GlobeNewswire January 10, 2017

Cytori Therapeutics to Provide Corporate Update at 2017 Biotech Showcase™

GlobeNewswire January 6, 2017

Cytori Announces Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund, LLC

GlobeNewswire December 29, 2016

Ronald Martell to Join Cytori Therapeutics’ Board of Directors

GlobeNewswire December 28, 2016

Cytori Pivotal ADRESU Incontinence Trial Hits 50% Enrollment Milestone

GlobeNewswire December 14, 2016

Cytori to Present at the 9th Annual LD Micro Main Event Conference on December 6th, 2016

GlobeNewswire December 5, 2016

Cytori Announces Two Year Follow-Up Published on EU Scleroderma Trial

GlobeNewswire November 29, 2016

Cytori Strengthens Global Intellectual Property Portfolio with Key Patents

Business Wire November 16, 2016

Cytori Granted FDA Orphan Drug Designation for ECCS-50 in Scleroderma

Business Wire November 14, 2016

Cytori Reports Third Quarter 2016 Business and Financial Results

Business Wire November 9, 2016

Cytori to Present Data in Two Distinct Models of Impaired Wound Healing

Business Wire November 4, 2016

Cytori to Webcast Third Quarter Financial Results on November 9

Business Wire October 26, 2016

Cytori Presents Scleroderma Clinical Trial Data at the 2016 American College of Rheumatology Annual Meeting

Business Wire October 26, 2016

Cytori Publication on Cytori Cell Therapy for Combined Radiation and Thermal Injury

Business Wire October 24, 2016

Cytori Partner Kerastem Completes Enrollment of US Phase II Trial for Early Stage Hair Loss

Business Wire September 26, 2016